Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension ; volume:7 ; number:1 ; day:27 ; month:9 ; year:2007 ; pages:1-8 ; date:12.2007
BMC ophthalmology ; 7, Heft 1 (27.9.2007), 1-8, 12.2007
- Creator
-
Frenkel, Ronald EP
- Contributor
-
Frenkel, Max
Toler, Allison
SpringerLink (Online service)
- DOI
-
10.1186/1471-2415-7-16
- URN
-
urn:nbn:de:1111-201604144310
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frenkel, Ronald EP
- Frenkel, Max
- Toler, Allison
- SpringerLink (Online service)
Other Objects (12)
Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review
Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review
Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review
Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension